Publications by authors named "Patrick C Barrett"

Background: In-person hand therapy is commonly prescribed for rehabilitation after thumb carpometacarpal (CMC) arthroplasty but may be burdensome to patients because of the need to travel to appointments. Asynchronous, video-assisted home therapy is a method of care in which videos containing instructions and exercises are provided to the patient, without the need for in-person or telemedicine visits. The purpose of the present study was to evaluate the effectiveness of providing video-only therapy (VOT) as compared with scheduled in-person therapy (IPT) after thumb CMC arthroplasty.

View Article and Find Full Text PDF

Unlabelled: Prior evidence is clear that in clean, elective soft-tissue hand procedures less than 2 hours, antibiotic prophylaxis is not indicated. However, there is a lack of consensus regarding the boney procedures of the hand involving implanted hardware. Previous studies reviewing complications after distal interphalangeal (DIP) joint arthrodesis did not analyze whether patients receiving antibiotics before surgery had a significant difference in the infection rate.

View Article and Find Full Text PDF

Purpose: We provide a systematic review of the current literature regarding best practices in postoperative care following carpometacarpal arthroplasty, and compare these findings to current practices via reported survey data.

Methods: The PubMed, Cochrane, Cumulative Index to Nursing and Allied Health Literature, Science Direct, and Google Scholar databases were searched for relevant studies. English-language articles were included that assessed any aspect of postoperative care, including the immobilization time or rehabilitation strategy.

View Article and Find Full Text PDF
Article Synopsis
  • Ru(II) complexes are being studied for their ability to produce cytotoxic effects in both oxygen-rich (normoxia) and oxygen-poor (hypoxia) environments, making them promising candidates for photochemotherapy (PCT).
  • The research focuses on how two different excited state pathways influence the effectiveness of these complexes using specific Ru(dmp)(IP-T) structures, which transition from metal-centered (MC) states to ligand-based (ILCT) states.
  • Findings show that certain complexes exhibit significant phototoxicity towards cancer cells in both normoxia and hypoxia, underscoring their potential as effective photosensitizers for cancer treatment, despite limitations in maximizing excited-state deactivation.
View Article and Find Full Text PDF
Article Synopsis
  • Hypoxia complicates cancer treatment by making tumors more aggressive and resistant to chemotherapy, highlighting the need for improved therapies.
  • The study introduces a promising metal-based photosensitizer, Os(phen)-IP-T, which shows outstanding performance, especially in low-oxygen conditions, with high phototherapeutic indices.
  • The photosensitizer exhibits low toxicity in the dark, increased phototoxicity with more thiophenes, and has a maximum tolerated dose in mice of over 200 mg/kg, demonstrating its potential for future cancer therapies.
View Article and Find Full Text PDF

In an earlier study of π-expansive ruthenium complexes for photodynamic and photochemo-therapies, it was shown that a pair of structural isomers differing only in the connection point of a naphthalene residue exhibited vastly different biological activity. These isomers are further explored in this paper through the activity of their functionalized derivatives. In normoxia, the inactive 2-NIP isomer (5) can be made as photocytotoxic as the active 1-NIP isomer (1) by functionalizing with methyl or methoxy groups, while methoxy variants of the 1-NIP isomer became inactive.

View Article and Find Full Text PDF

Hypoxia presents a challenge to anticancer therapy, reducing the efficacy of many available treatments. Photodynamic therapy is particularly susceptible to hypoxia, given that its mechanism relies on oxygen. Herein, we introduce two new osmium-based polypyridyl photosensitizers that are active in hypoxia.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied a series of modified Ru(II) complexes to evaluate their anticancer potential in low-oxygen (hypoxic) environments.
  • These complexes featured specially designed ligands, allowing for altered photochemical behaviors and impacts on cancer cell toxicity when exposed to specific light wavelengths.
  • Notably, one complex maintained effectiveness in hypoxic conditions, demonstrating a high photocytotoxicity index (PI) compared to typical Ru(II) complexes, highlighting its potential for targeted cancer therapies.
View Article and Find Full Text PDF

A new family of cyclometalated ruthenium(II) complexes [Ru(N^N)(C^N)] derived from the π-extended benzo[]imidazo[4,5-]quinolone ligand appended with thienyl groups ( = 1-4, compounds -) was prepared and its members were characterized for their chemical, photophysical, and photobiological properties. The lipophilicities of -, determined as octanol-water partition coefficients (log ), were positive and increased with the number of thienyl units. The absorption and emission bands of the C^N compounds were red-shifted by up to 200 nm relative to the analogous Ru(II) diimine systems.

View Article and Find Full Text PDF